13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico

Exclusion Criteria

• •History of allergic reaction to any vaccine
• •Previous vaccination with licensed or experimental pneumococcal vaccine
• •S. pneumonia infection within past 5 years before investigational product administration
• •Known or suspected immunodeficiency or received treatment including cytotoxic agents or systemic corticosteroids, serious chronic disorder such as malignancy cancer
• •Receipt of plasma products or immunoglobulins within 60 days
• •Bleeding conditions or diathesis
• •Receipt of investigational product within 28 days before study entry
• •Other severe acute or chronic medical or psychiatric condition